A pilot study of whole body hyperthermia and carboplatin in platinum-resistant ovarian cancer

European Journal of Cancer

Volumn 37, Issue 9, 2001, Pages 1111-1117

  Westermann, A M ^a   Grosen, E A ^b   Katschinski, D M ^c   Jager D ^d   Rietbroek, R ^a   Schink, J C ^b   Tiggelaar, C L ^b   Jager E ^d   Zum Vorde sive Vording P ^a   Neuman, A ^d   Knuth, A ^d   Van Dijk, J D P ^a   Wiedemann, G J ^c   Robins, H I ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF WISCONSIN   (United States)

^c UNIVERSITY OF LÜBECK   (Germany)

^d KRANKENHAUS NORDWEST   (Germany)

Author keywords

Carboplatin; Ovarian cancer; Platinum resistance; Whole body hyperthermia

Indexed keywords

ANTIEMETIC AGENT; CARBOPLATIN; PLATINUM; SEDATIVE AGENT;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD TOXICITY; BONE MARROW SUPPRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; HYPERTHERMIA; INTESTINE OBSTRUCTION; NAUSEA; NEUTROPENIA; OVARY CARCINOMA; PRIORITY JOURNAL; TEMPERATURE; THROMBOCYTOPENIA; VOMITING;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARBOPLATIN; COMBINED MODALITY THERAPY; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; MIDDLE AGED; OVARIAN NEOPLASMS; PILOT PROJECTS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0034995155     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(01)00074-0     Document Type: Article

References (25)

1. Hyperthermia enhancement of cis-diammine-1, 1-cyclobutane dicarboxylate platinum(II) cytotoxicity in human leukemia cells in vitro
2. Tumoricidal interactions of hyperthermia with carboplatin, cisplatin and ectoposide
3. Interactions of thymidine, hyperthermia and cis-diammine-1, 1-cyclobutane dicarboxylate platinum (II) in human T cell leukemia
4. Thermal enhancement of tetraplatin and carboplatin in human leukemia cells in vitro
5. Radiosensitization of C6 glioma by thymidine and 41.8°C hyperthermia
6. Effect of carboplatin combined with whole body hyperthermia on normal tissue and tumor in rats
7. Whole body hyperthermia and carboplatin: Cytotoxicity for murine leukemia and normal marrow
8. Early clinical studies with cis-diammine-1, 1-cyclobutane dicarboxplate platinum II
9. Phase I evaluation of carboplatin at 37°C and 42°C in tumor-bearing dogs
10. Sensitization of C6 glioma to carboplatin cytotoxicity by hyperthermia and thymidine
11. Hyperthermic potentiation of cis-diamminedichloroplatinum (II) cytotoxicity in Chinese hamster ovary cells
12. Phase I clinical trial of carboplatin and 41.8°C whole body hyperthermia in cancer patients
13. Cytokine induction in humans by 41.8°C whole body hyperthermia
14. Whole body hyperthermia cytokine induction: A review, and unifying hypothesis for myeloprotection in the setting of cytotoxic therapy
15. Cytokine induction by 41.8°C whole body hyperthermia
16. Whole body hyperthermia: Biological, and clinical aspects
17. Biology and methodology of whole body hyperthermia
18. Temperature gradients between the rectum and bone marrow in dogs during whole body hyperthermia
19. Optimization of chemotherapy administration for clinical 41.8°C whole body hyperthermia
20. Carboplatin dosage: Prospective evaluation of a simple formula based on renal function
21. A non-toxic system for 41.8°C whole body hyperthermia: Results of a phase I study using a radiant heat device
22. A new technological approach to radiant heat whole body hyperthermia
23. Effect of hyperthermia in vitro and in vivo on adenine and pyridine nucleotide pools in human peripheral lymphocytes
24. Predicting grade 3 or greater myelotoxicity to carboplatin in advanced ovarian cancer patients
25. Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer